Verastem | VSTM - Себестоимость





Себестоимость Изменить Дата
AbbVie USD 4.29B 73M 2026-06
Alaunos Therapeutics USD 0 18K 2024-09
AstraZeneca USD 2.52B 2.73B 2026-06
Curis USD 314K 9.96M 2025-12
Cytokinetics USD 5.59M 5.43M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
Incyte USD 104.96M 457K 2026-06
Laboratory Of America USD 2.7B 97.8M 2026-06
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.09B 498M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
TG Therapeutics USD 41.19M 7.68M 2026-06
Verastem USD 3.05M 159K 2026-03